可编程的iPSC衍生的CAR-NK囊泡重塑免疫微环境并根除瘤
Hao Zhang1, Shenglong Li2, Chongzhong Liu3
1Department of Organ transplant, Qilu Hospital of Shandong University, Shandong University, Jinan, Shandong, China; Second Qilu Hospital of Shandong University, Shandong University, Jinan, Shandong, China.
Cell reports. Medicine
|February 6, 2026
概括
化学抗原受体 (CAR) 设计的自然杀手细胞细胞外囊泡 (CAR-iNEVs) 为固体瘤提供无细胞治疗. 这些CAR-iNEVs向瘤并增强免疫微环境,表现出强大的抗瘤活性.
科学领域:
- 免疫学 免疫学 免疫学
- 在瘤学瘤学.
- 生物技术是生物技术.
背景情况:
- 化学抗原受体 (CAR) 细胞疗法对血液癌症有效,但在固体瘤中面临挑战.
- 固体瘤存在着树皮屏障和免疫抑制的微环境,限制了免疫细胞的透和有效性.
- 现有的CAR细胞疗法依赖于活细胞,这给固体瘤治疗带来了交付和安全问题.
研究的目的:
- 开发一种用于固体瘤的无细胞治疗平台,使用CAR工程诱导多能干细胞 (iPSC) 衍生的自然杀手 (NK) 细胞外囊泡 (CAR-iNEVs).
- 在固体瘤模型中评估CAR-iNEVs的抗瘤活性,耐受性和作用机制.
- 研究CAR-iNEVs与其他免疫疗法 (如免疫检查点阻塞和CD47抑制) 的协同作用潜力.
主要方法:
- 开发CAR工程的iPSC衍生的NK细胞外囊泡 (CAR-iNEVs).
- 评估CAR-iNEV抗瘤活性和耐受性在多重异种移植和患者衍生的固体瘤模型中.
- 涉及CAR-iNEV介导的瘤细胞消除,瘤微环境调制和免疫细胞相互作用的机制研究.
- 使用CAR-iNEV和免疫检查点阻塞或CD47抑制的组合疗法研究.
主要成果:
- 在临床前的固体瘤模型中,CAR-iNEVs表现出强大的直接抗瘤活性和出色的耐受性.
- 已证明,CAR-iNEVs通过促进促炎性巨细胞两极分化来重塑瘤微环境,增强先天抗瘤免疫力.
- 在幸存的小鼠中,CAR-iNEVs与CD47抑制的联合治疗导致瘤清除增加,并诱导长期免疫记忆.
- 在不需要活细胞输送的情况下,CAR-iNEVs有效地向瘤,克服了传统CAR细胞疗法的局限性.
结论:
- CAR-iNEVs代表了一种有前途的无细胞治疗策略,用于克服固体瘤障碍和免疫抑制.
- 这个平台有效地准瘤细胞并调节瘤微环境以提高宿主免疫力.
- CAR-iNEVs显示了与其他免疫疗法结合的潜力,以改善固体瘤治疗结果并诱导持久记忆反应.
相关概念视频
The Tumor Microenvironment
7.8K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
7.8K
Immune Surveillance by NK Cells and Phagocytes
8.8K
Immune surveillance is an integral part of the innate immune system, involving the continuous monitoring of peripheral tissues to detect and respond to pathogens, infected cells, or cancerous cells. This surveillance is conducted primarily by natural killer (NK) cells and phagocytes, which employ distinct but complementary mechanisms to identify and eliminate threats.
Natural Killer Cells: The Fast Responders
NK cells are large granular lymphocytes found in the blood and lymphatic system. These...
Natural Killer Cells: The Fast Responders
NK cells are large granular lymphocytes found in the blood and lymphatic system. These...
8.8K
Nucleosome Remodeling
11.2K
Nucleosomes are the basic units of chromatin compaction. Each nucleosome consists of the DNA bound tightly around a histone core, which makes the DNA inaccessible to DNA binding proteins such as DNA polymerase and RNA polymerase. Hence, the fundamental problem is to ensure access to DNA when appropriate, despite the compact and protective chromatin structure.
Nucleosome remodeling complex
Eukaryotic cells have specialized enzymes called ATP-dependent nucleosome remodeling enzymes. These enzymes...
Nucleosome remodeling complex
Eukaryotic cells have specialized enzymes called ATP-dependent nucleosome remodeling enzymes. These enzymes...
11.2K
Bone Remodeling
40.5K
Bone remodeling is a continuous and balanced process of bone resorption by osteoclasts and bone formation by osteoblasts. In adults, it helps maintain bone mass and calcium homeostasis. While mechanical stress can stimulate turnover as part of the normal maintenance and reparative process, several hormones also regulate bone remodeling.
40.5K
What is the Immune System?
130.8K
Overview
130.8K
Osteoclasts in Bone Remodeling
4.2K
Osteoclasts are cells responsible for bone resorption and remodeling. They originate from hematopoietic progenitor cells present in the bone marrow. Numerous progenitor cells fuse to form multinucleated cells, each with 10-20 nuclei. A single osteoclast has a diameter of 150 to 200 µM. These cells have ruffled borders that break down the underlying bone tissue and release minerals such as calcium into the blood in bone resorption. Osteoclasts cling to bones with their ruffled edges during...
4.2K


